Do COVID vaccines prevent long COVID: Beyond the 3-months mark?

Helen Petousis-Harris, BSc, PGDipSci (Dist), PhD

One of the most perplexing health challenges associated with the COVID-19 pandemic is the enigmatic condition known as long COVID. As the name suggests, it refers to a multitude of symptoms and conditions that persist beyond three-months after someone has been infected with the virus. These symptoms cannot be explained by other diagnoses, making it a puzzle that continues to baffle researchers and healthcare professionals alike.

Provocative headlines on a post-COVID vaccination syndrome

Helen Petousis-Harris, BSc, PGDipSci (Dist), PhD

Vaccines authorised for use are incredibly safe, but the risk for serious side effects is not ‘0’. Vaccine safety scientists exist because vaccines are not 100% safe. Just to be clear, nothing in the multi-verse is 100% safe but vaccines can come pretty close. The risks of COVID-19 disease are far greater than risks posed by the vaccines.

Vaccine safety signals – What are they and what to do when you find one

Helen Petousis-Harris, BSc, PGDipSci (Dist), PhD

Vaccine safety signals are essential to stimulate questions about the potential relationship between a vaccine and an adverse event. However, it is crucial to follow a sequence of steps and conduct confirmatory studies before concluding a causal relationship between the vaccine and the adverse event exists. Good communication and appropriately designed association studies are critical steps in validating a safety signal.

NZ Gold Study

The New Zealand Gold Study includes a suite of observational studies to assess the risk of adverse events of special interest following COVID-19 and mpox vaccines in Aotearoa New Zealand using a gold standard approach. The work also includes contribution to a genomics study.